Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study

BACKGROUND: There is limited evidence on the use of high-sensitivity C-reactive protein (hsCRP) as a biomarker for selecting patients for advanced cardiovascular (CV) therapies in the modern era. The prognostic value of mildly elevated hsCRP beyond troponin in a large real-world cohort of unselected...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaura, Amit, Hartley, Adam, Panoulas, Vasileios, Glampson, Ben, Shah, Anoop S. V., Davies, Jim, Mulla, Abdulrahim, Woods, Kerrie, Omigie, Joe, Shah, Anoop D., Thursz, Mark R., Elliott, Paul, Hemmingway, Harry, Williams, Bryan, Asselbergs, Folkert W., O’Sullivan, Michael, Lord, Graham M., Trickey, Adam, Sterne, Jonathan AC, Haskard, Dorian O., Melikian, Narbeh, Francis, Darrel P., Koenig, Wolfgang, Shah, Ajay M., Kharbanda, Rajesh, Perera, Divaka, Patel, Riyaz S., Channon, Keith M., Mayet, Jamil, Khamis, Ramzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863282/
https://www.ncbi.nlm.nih.gov/pubmed/35192610
http://dx.doi.org/10.1371/journal.pmed.1003911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863282/
https://www.ncbi.nlm.nih.gov/pubmed/35192610
http://dx.doi.org/10.1371/journal.pmed.1003911

Ejemplares similares